Skip to content

Clinical Study of Non-invasive Neuromodulation Techniques-temporal interference stimulation for Pediatric Dystonia

Clinical Study of Non-invasive Neuromodulation Techniques-temporal interference stimulation for Pediatric Dystonia

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123960
Enrollment
Unknown
Registered
2026-05-05
Start date
2026-05-06
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dystonia

Interventions

Sponsors

Shanghai Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Age: 3 - 18 years old, gender not restricted; 2. Meets the diagnostic criteria of the Chinese Neurology Society's "Chinese Expert Consensus on the Diagnosis of Dystonia"; 3. Has not achieved satisfactory results with drug treatment (such as at least two drugs still cause significant dystonia or are intolerable) or cannot tolerate the drugs, and has not accepted drug treatment and is not undergoing any other neuroregulation treatment at present; 4. Can cooperate to complete neuroregulation intervention and follow-up assessment; 5. Has signed the informed consent form (for >= 8-year-old participants, both the individual and the guardian need to sign; for < 8-year-old participants, the guardian only needs to sign).

Exclusion criteria

Exclusion criteria: 1. Prior history of deep brain stimulation (DBS) or other cranial surgery; 2. Presence of severe psychiatric or behavioral disorders (meeting internationally recognized diagnostic criteria, e.g., DSM-5 or ICD-10/11, and causing significant and persistent impairment in cognition, emotion, or behavior), making the participant unable to comply with the study; 3. Significant skin lesions, infection, allergy, or damage at the electrode placement site; 4. Participation in other interventional clinical studies involving drugs or medical devices within 1 month prior to enrollment; 5. Any condition that, in the investigator’s judgment, may compromise patient safety or affect the evaluation of efficacy

Design outcomes

Primary

MeasureTime frame
Improvement rate in severity of dystonia;

Secondary

MeasureTime frame
Improvement rate in gross motor function;Quality of life of children;Changes in self-harm frequency;

Countries

China

Contacts

Public ContactXiaolai Ye

Shanghai Children's Medical Center

xiaolai0226@163.com+86 180 1970 9229

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026